Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $17.78 and traded as high as $18.34. Terumo shares last traded at $17.56, with a volume of 389,522 shares trading hands.
Terumo Stock Performance
The stock's 50-day moving average is $17.73 and its 200 day moving average is $18.34. The firm has a market cap of $25.67 billion, a P/E ratio of 33.35 and a beta of 0.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.78 and a current ratio of 3.00.
Terumo (OTCMKTS:TRUMY - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). The firm had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.79 billion. Terumo had a return on equity of 8.48% and a net margin of 11.28%.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Featured Stories
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.